Homologous News and Research

RSS

Research looks at potential of pantethine against SARS-CoV-2

In a recent study posted to the Research Square preprint server, researchers assessed the antiviral activity of pantethine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

12 May 2022

Study estimates effectiveness of 2-dose and 3-dose mRNA vaccination against Omicron

In a recent study posted to the medRxiv* preprint server, researchers estimated the efficacy of two-dose and three-dose regimens of two messenger ribonucleic acid (mRNA) vaccines: Moderna’s mRNA-1273 and Pfizer-BioNTech’s BNT162b2 against coronavirus disease 2019 (COVID-19) caused due to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron variant.

12 May 2022

Research describes how DNA damage can affect neural health and function

A new research paper in the journal EMBO Reports describes how DNA damage can affect neural health and function.

12 May 2022

Study investigates antibody-mediated response against different SARS-CoV-2 variants

In a recent study posted to the bioRxiv* preprint server, researchers assessed the impact of coronavirus disease 2019 (COVID-19) on antibody-mediated immunity.

10 May 2022

mRNA boosters enhance neutralization of SARS-CoV-2 BA.1, BA.2 and BA.3

A study recently published in the journal Cell Host & Microbe has described that all three sublineages of the omicron variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) exhibit similar host cell entry efficiency and are neutralized equally by antibodies generated in response to coronavirus disease 2019 (COVID-19) booster vaccination

10 May 2022

Evaluating immune protection after third and fourth doses of homologous and heterologous SARS-CoV-2 vaccines among kidney transplant recipients

Researchers evaluated the immune responses after the third and fourth doses of homologous and heterologous mRNA vaccines against COVID-19 in kidney transplant recipients.

4 May 2022

CRISPR/Cas9 deletions induce adverse on-target genomic effects

Researchers utilized a CRISPR/Cas9 system to evaluate the usage of tRNA by deleting two tRNA genes from the genomes of hyper hepatocellular carcinoma and human near-haploid chronic myeloid leukemia cells.

27 Apr 2022

Research highlights importance of booster vaccine doses to protect against all Omicron variants

In a recent study published in the Cell Host and Microbe journal, researchers examined the neutralization of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron BA.1, BA.1.1, and BA.2 sublineages.

27 Apr 2022

Effectiveness of CoronaVac, AZD1222, and BNT162b2 vaccine boosters

The researchers assessed the efficacy of homologous and heterologous booster doses of SARS-CoV-2 vaccines.

26 Apr 2022

Recipients for the 2022 NCCN Foundation Young Investigator Awards Program announced

The National Comprehensive Cancer Network and the NCCN Foundation today announced seven recipients for the 2022 NCCN Foundation Young Investigator Awards (YIA) Program.

25 Apr 2022

Vaccine effectiveness against symptomatic disease caused by the Omicron and Delta variants in England

The researchers aimed to estimate how effective vaccination was against severe COVID-19, caused by Omicron and Delta variants of the virus, in England.

25 Apr 2022

Study suggests BCG vaccination might confer immunity to SARS-CoV-2

In a recent study posted to the bioRxiv* preprint server, the researchers investigated the impact of Bacillus Calmette-Guérin (BCG) vaccine-induced antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike (S) glycoprotein.

25 Apr 2022

Quercetin and other plant flavonols show anti-SARS-CoV-2 activity

A new study discusses the potential of certain plant compounds to block SARS-CoV-2 replication within host cells.

24 Apr 2022

Heterologous booster dose leads to better SARS-CoV-2 vaccine performance, study shows

A new study on Chile's national COVID-19 vaccination program, to be presented at this year's European Congress of Clinical Microbiology & Infectious Diseases (ECCMID 2022, Lisbon 23-26), and published in The Lancet Global Health, shows that giving a different type of vaccine (heterologous) for the third or 'booster' dose than was received for the first two doses, leads to better vaccine performance than using the same (homologous) inactivated SARS-CoV-2 vaccine for all three doses.

24 Apr 2022

Study suggests SARS-CoV-2 is undergoing evolutionary changes at the functional RNA level in addition to the amino acid level

Researchers demonstrated SARS-CoV-2 evolution at the transcriptional level.

22 Apr 2022

Polyethylene glycol-specific antibody responses induced by mRNA-1273 COVID-19 vaccine

Researchers determined the impact of COVID-19 vaccines on polyethylene glycol-specific antibody responses.

20 Apr 2022

Study finds two doses of mRNA or ChAdOx1 vaccines provide excellent protection against severe outcomes of hospitalization and death

Researchers assessed the effectiveness of COVID-19 vaccines against related hospitalizations and death.

18 Apr 2022

Homologous News and Research

Research looks at potential of pantethine against SARS-CoV-2

Study estimates effectiveness of 2-dose and 3-dose mRNA vaccination against Omicron

Research describes how DNA damage can affect neural health and function

Study investigates antibody-mediated response against different SARS-CoV-2 variants

mRNA boosters enhance neutralization of SARS-CoV-2 BA.1, BA.2 and BA.3

Evaluating immune protection after third and fourth doses of homologous and heterologous SARS-CoV-2 vaccines among kidney transplant recipients

CRISPR/Cas9 deletions induce adverse on-target genomic effects

Research highlights importance of booster vaccine doses to protect against all Omicron variants

Effectiveness of CoronaVac, AZD1222, and BNT162b2 vaccine boosters

Recipients for the 2022 NCCN Foundation Young Investigator Awards Program announced

Vaccine effectiveness against symptomatic disease caused by the Omicron and Delta variants in England

Study suggests BCG vaccination might confer immunity to SARS-CoV-2

Quercetin and other plant flavonols show anti-SARS-CoV-2 activity

Heterologous booster dose leads to better SARS-CoV-2 vaccine performance, study shows

Study suggests SARS-CoV-2 is undergoing evolutionary changes at the functional RNA level in addition to the amino acid level

Polyethylene glycol-specific antibody responses induced by mRNA-1273 COVID-19 vaccine

Study finds two doses of mRNA or ChAdOx1 vaccines provide excellent protection against severe outcomes of hospitalization and death

Durable neutralizing response against Omicron after heterologous vaccine boosting

Recent advances in non-viral nano-vector delivery of CRISPR/Cas9 genome editing payloads

Researchers find novel inhibitors that may suppress oncogenesis of metastatic prostate cancer

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News